These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9056798)

  • 21. Should tamoxifen users be screened for endometrial lesions?
    Neven P; Vergote I
    Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
    [No Abstract]   [Full Text] [Related]  

  • 22. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia.
    Mansel RE; Goyal A; Preece P; Leinster S; Maddox PR; Gateley C; Kubista E; von Fournier D
    Am J Obstet Gynecol; 2004 Dec; 191(6):1942-9. PubMed ID: 15592276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tamoxifen ruling in California.
    Mack T
    Science; 1995 Nov; 270(5239):1102-3. PubMed ID: 7502022
    [No Abstract]   [Full Text] [Related]  

  • 24. The beneficial effect of the estrogen antagonist tamoxifen on experimental systemic lupus erythematosus.
    Thylan S
    J Rheumatol; 1995 Aug; 22(8):1606-7. PubMed ID: 7473493
    [No Abstract]   [Full Text] [Related]  

  • 25. [Tamoxifen and endometrial cancer].
    Salamanca-Gómez F
    Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554
    [No Abstract]   [Full Text] [Related]  

  • 26. ACOG committee opinion. Tamoxifen and endometrial cancer. Number 169, February 1996. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 1996 May; 53(2):197-9. PubMed ID: 8735304
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed severe hypertriglyceridemia from tamoxifen.
    Kanel KT; Wolmark N; Thompson PD
    N Engl J Med; 1997 Jul; 337(4):281. PubMed ID: 9229698
    [No Abstract]   [Full Text] [Related]  

  • 28. Tamoxifen for breast cancer prevention.
    Force RW
    J Fam Pract; 1998 Nov; 47(5):336-7. PubMed ID: 9834765
    [No Abstract]   [Full Text] [Related]  

  • 29. [Osteoporosis as the long-term adverse effect of tumor treatment].
    Łacko A; Włodarska I; Wróbel T
    Pol Arch Med Wewn; 2001 Jan; 105(1):71-8. PubMed ID: 11505703
    [No Abstract]   [Full Text] [Related]  

  • 30. One step forward or one step back with tamoxifen?
    Gelmon K
    Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
    [No Abstract]   [Full Text] [Related]  

  • 31. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
    Gnant MF; Mlineritsch B; Luschin-Ebengreuth G; Grampp S; Kaessmann H; Schmid M; Menzel C; Piswanger-Soelkner JC; Galid A; Mittlboeck M; Hausmaninger H; Jakesz R;
    J Clin Oncol; 2007 Mar; 25(7):820-8. PubMed ID: 17159195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased seizure threshold related to tamoxifen.
    Stewart JT; Kahn DA
    J Psychiatr Pract; 2014 Nov; 20(6):476-8. PubMed ID: 25406053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massive endometrial polyp after tamoxifen therapy.
    Divers MJ
    Br J Clin Pract; 1995; 49(5):275-6. PubMed ID: 7492471
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA issues warning about 'new' tamoxifen risk.
    Twombly R
    J Natl Cancer Inst; 2002 Aug; 94(15):1122. PubMed ID: 12165635
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of painless thyroiditis possibly triggered by tamoxifen citrate, a synthetic antiestrogen.
    Watanobe H; Kawabe H
    J Endocrinol Invest; 1998 Jan; 21(1):70-1. PubMed ID: 9633027
    [No Abstract]   [Full Text] [Related]  

  • 36. Mastalgia: evaluation and management.
    Padden DL
    Nurse Pract Forum; 2000 Dec; 11(4):213-8. PubMed ID: 11220018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of tamoxifen on the uterus.
    Ismail SM
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic epidermal necrolysis with the use of tamoxifen.
    Madabhavi I; Revannasiddaiah S; Patel A; Anand A
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25878231
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs.
    Yang G; Nowsheen S; Aziz K; Georgakilas AG
    Pharmacol Ther; 2013 Sep; 139(3):392-404. PubMed ID: 23711794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen for the prevention of breast cancer.
    Greenspan EM
    Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.